ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,227, issued on Sept. 9, was assigned to ELI LILLY AND COMPANY (Indianapolis).
"Incretin analogs and uses thereof" was invented by Milata Mary Abraham (Indianapolis), Jorge Alsina-Fernandez (Indianapolis), Tamer Coskun (Carmel, Ind.), Hongchang Qu (Carmel, Ind.) and James Lincoln Wallis (Indianapolis).
According to the abstract* released by the U.S. Patent & Trademark Office: "Incretin analogs are provided that have activity at each of the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors. The incretin analogs have structural features resulting in balanced activity and extended duration of action at each of these rece...